Exploiting the Synergy between Carboplatin and ABT-737 in the Treatment of Ovarian Carcinomas

Open Access

Peer-reviewed

Research Article

Harsh Vardhan Jain ,

* E-mail: hjain@fsu.edu

Affiliation Department of Mathematics, Florida State University, Tallahassee, Florida,United States of America
⨯
Alan Richardson,

Affiliation Institute for Science and Technology in Medicine, Keele University, Stoke-on-Trent, United Kingdom
⨯
Michael Meyer-Hermann,

Affiliations Department of Systems Immunology, Helmholtz Centre for Infection Research, Braunschweig, Germany, Bio Centre for Life Science, Braunschweig University of Technology, Braunschweig, Germany
⨯
Helen M. Byrne

Affiliations Oxford Centre for Collaborative and Applied Mathematics, Mathematical Institute, University of Oxford, Oxford, United Kingdom, Department of Computer Science, University of Oxford, Oxford, United Kingdom
⨯

Reader Comments (0)

Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Ovarian cancer
Is the Subject Area "Ovarian cancer" applicable to this article?

Thanks for your feedback.
Dose prediction methods
Is the Subject Area "Dose prediction methods" applicable to this article?

Thanks for your feedback.
Malignant tumors
Is the Subject Area "Malignant tumors" applicable to this article?

Thanks for your feedback.
Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Pharmacokinetics
Is the Subject Area "Pharmacokinetics" applicable to this article?

Thanks for your feedback.
Drug administration
Is the Subject Area "Drug administration" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.